These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

732 related items for PubMed ID: 1333745

  • 1. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
    Mygland A, Tysnes OB, Matre R, Volpe P, Aarli JA, Gilhus NE.
    Ann Neurol; 1992 Oct; 32(4):589-91. PubMed ID: 1333745
    [Abstract] [Full Text] [Related]

  • 2. IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma.
    Mygland A, Tysnes OB, Aarli JA, Matre R, Gilhus NE.
    J Autoimmun; 1993 Aug; 6(4):507-15. PubMed ID: 8216692
    [Abstract] [Full Text] [Related]

  • 3. Anti-cardiac ryanodine receptor antibodies in thymoma-associated myasthenia gravis.
    Mygland A, Tysnes OB, Matre R, Aarli JA, Gilhus NE.
    Autoimmunity; 1994 Aug; 17(4):327-31. PubMed ID: 7948615
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Myasthenia gravis sera containing antiryanodine receptor antibodies inhibit binding of [3H]-ryanodine to sarcoplasmic reticulum.
    Skeie GO, Lunde PK, Sejersted OM, Mygland A, Aarli JA, Gilhus NE.
    Muscle Nerve; 1998 Mar; 21(3):329-35. PubMed ID: 9486861
    [Abstract] [Full Text] [Related]

  • 6. Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin.
    Williams CL, Hay JE, Huiatt TW, Lennon VA.
    Lab Invest; 1992 Mar; 66(3):331-6. PubMed ID: 1538587
    [Abstract] [Full Text] [Related]

  • 7. Myasthenia gravis-associated ryanodine receptor antibodies inhibit binding of ryanodine to sarcoplasmic reticulum.
    Skeie GO, Lunde PK, Sejersted OM, Mygland A, Aarli JA, Gilhus NE.
    Ann N Y Acad Sci; 1998 May 13; 841():530-3. PubMed ID: 9668288
    [No Abstract] [Full Text] [Related]

  • 8. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L, Andreetta F, Antozzi C, Confalonieri P, Cornelio F, Scaioli V, Mantegazza R.
    Neuromuscul Disord; 2008 Aug 13; 18(8):678-80. PubMed ID: 18657424
    [Abstract] [Full Text] [Related]

  • 9. [Determination and clinical significance of serum anti-ryanodine receptor antibody in patients with myasthenia gravis].
    Cui LY, Li YF, Li YH, Zhang JB.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Apr 13; 29(2):238-40. PubMed ID: 17536276
    [Abstract] [Full Text] [Related]

  • 10. [Autoantibodies in thymoma-associated myasthenia gravis and their clinical significance].
    Suzuki S.
    Brain Nerve; 2011 Jul 13; 63(7):705-12. PubMed ID: 21747140
    [Abstract] [Full Text] [Related]

  • 11. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
    Rigamonti A, Lauria G, Piamarta F, Fiumani A, Agostoni E.
    J Neurol Sci; 2011 Mar 15; 302(1-2):112-3. PubMed ID: 21236448
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Autoimmunity against the ryanodine receptor in myasthenia gravis.
    Skeie GO, Lunde PK, Sejersted OM, Mygland A, Aarli JA, Gilhus NE.
    Acta Physiol Scand; 2001 Mar 15; 171(3):379-84. PubMed ID: 11412151
    [Abstract] [Full Text] [Related]

  • 14. Anti-titin and antiryanodine receptor antibodies in myasthenia gravis patients with thymoma.
    Baggi F, Andreetta F, Antozzi C, Simoncini O, Confalonieri P, Labeit S, Cornelio F, Mantegazza R.
    Ann N Y Acad Sci; 1998 May 13; 841():538-41. PubMed ID: 9668290
    [No Abstract] [Full Text] [Related]

  • 15. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J, Murakawa T, Fukami T, Sano A, Takamoto S, Ohtsu H.
    Ann Thorac Surg; 2008 Sep 13; 86(3):941-5. PubMed ID: 18721587
    [Abstract] [Full Text] [Related]

  • 16. [Anti-ryanodine receptor antibody and the thymus gland in myasthenia gravis].
    Iwasa K, Asaka T, Takamori M.
    Nihon Naika Gakkai Zasshi; 1998 Apr 10; 87(4):655-63. PubMed ID: 9627474
    [No Abstract] [Full Text] [Related]

  • 17. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies.
    Romi F, Skeie GO, Aarli JA, Gilhus NE.
    Arch Neurol; 2000 Nov 10; 57(11):1596-600. PubMed ID: 11074791
    [Abstract] [Full Text] [Related]

  • 18. Titin and ryanodine receptor autoantibodies in dogs with thymoma and late-onset myasthenia gravis.
    Shelton GD, Skeie GO, Kass PH, Aarli JA.
    Vet Immunol Immunopathol; 2001 Jan 10; 78(1):97-105. PubMed ID: 11182151
    [Abstract] [Full Text] [Related]

  • 19. Ryanodine receptor antibodies in myasthenia gravis: epitope mapping and effect on calcium release in vitro.
    Skeie GO, Mygland A, Treves S, Gilhus NE, Aarli JA, Zorzato F.
    Muscle Nerve; 2003 Jan 10; 27(1):81-9. PubMed ID: 12508299
    [Abstract] [Full Text] [Related]

  • 20. [Molecular mimicry between neurofilaments and titin as the basis for autoimmunity towards skeletal muscle in paraneoplastic myasthenia gravis].
    Wilisch A, Schultz A, Greiner A, Kirchner T, Müller-Hermelink HK, Marx A.
    Verh Dtsch Ges Pathol; 1996 Jan 10; 80():261-6. PubMed ID: 9065023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.